Dr. Terry Heiman-Patterson Offers Insight to Associated Press for Article about Stem Cell-Based Therapy for Patients with ALS

Terry Heiman-Patterson, MD, Director of the Temple MDA/ALS Center of Hope, offered insight to the Associated Press for an article about NurOwn, a stem cell-based therapy for patients with ALS, or amyotrophic lateral sclerosis. At the time, the treatment was awaiting approval by the U.S. Food and Drug Administration (FDA). The FDA eventually voted against the therapy.